Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide With or Without NEAT in Type 2 Diabetes
NCT01638260Phase 4Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2012
- Primary completion
- Nov 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Maastricht University Medical Center+. Started Oct 2012; status: terminated.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01638260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638260.